CVS Group plc (LON:CVSG – Get Free Report) shares traded up 1.2% on Monday. The company traded as high as GBX 1,379 and last traded at GBX 1,370. 389,990 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 867,277 shares. The stock had previously closed at GBX 1,354.25.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on CVSG. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a report on Monday, July 27th. Jefferies Financial Group reiterated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a report on Friday, September 25th. Shore Capital Group reissued a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a research report on Thursday, September 24th. Finally, Berenberg Bank restated a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, September 24th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, CVS Group presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.
View Our Latest Stock Analysis on CVS Group
CVS Group Price Performance
The company’s 50-day simple moving average is GBX 1,277.01 and its 200-day simple moving average is GBX 1,254.24. The company has a debt-to-equity ratio of 110.41, a current ratio of 1.18 and a quick ratio of 0.90. The stock has a market capitalization of £913.72 million, a price-to-earnings ratio of 56.38, a P/E/G ratio of 1.77 and a beta of 1.07.
CVS Group (LON:CVSG – Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. Research analysts forecast that CVS Group plc will post 93.94 earnings per share for the current fiscal year.
CVS Group Company Profile
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Further Reading
- Five stocks we like better than CVS Group
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
